The Efficacy and Safety of Administration of the COX-2 Selective NSAID, Etoricoxib (120mg od. for 7 Days) Compared to Diclofenac (50 mg Tds. for 7 Days) and Placebo as Adjunct Treatment in the First 7 Days of Treatment of Acute Grade II Lateral Ankle Ligaments Sprains: A Clinical Trial
Latest Information Update: 11 May 2022
At a glance
- Drugs Etoricoxib (Primary) ; Diclofenac
- Indications Musculoskeletal pain
- Focus Therapeutic Use
- 19 Aug 2009 New trial record